老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Reviva Pharmaceuticals Holdings, Inc.

0.7709
-0.0741-8.77%
盘后：0.78000.0091+1.18%19:59 EDT
成交量：48.42万
成交额：38.14万
市值：981.12万
市盈率：-0.14
高：0.8568
开：0.8568
低：0.7600
收：0.8450
52周最高：23.20
52周最低：0.5900
股本：1,272.70万
流通股本：1,255.13万
量比：0.54
换手率：3.86%
股息：- -
股息率：- -
每股收益(TTM):-5.4800
每股收益(LYR):-18.0520
净资产收益率：-419.97%
总资产收益率：-80.35%
市净率：1.13
市盈率(LYR):-0.04

数据加载中...

总览公司新闻资讯公告
2021/11/15

重要事件披露

8-K - Current report
2021/09/20

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/16

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/06/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/19

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/07

重要事件披露

8-K - Current report
2021/05/07

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/19

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/04/15

重要事件披露

8-K - Current report
2021/03/24

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
更多